Cagrilintide (also known as 0833) is a synthetic, long-acting acylated peptide analogue of human amylin, consisting of 37 amino acids with targeted sequence modifications and N-terminal lipidation via a γ-glutamyl-linked eicosanedioic acid (C20 diacid) fatty chain for enhanced stability and pharmacokinetic properties. Its primary sequence incorporates substitutions such as Asn14Glu and Val17Arg for improved solubility and helix stabilization via salt bridge formation, multiple proline insertions (e.g., at positions 25, 28, 29) to reduce β-sheet propensity and amyloid fibril formation, and a C-terminal proline amidation; it features a disulfide bridge between Cys³ and Cys⁸.
Store in a cool, dark place or freeze at -20°C for long term storage. Refredgerate after reconstitution
Product Name: Cagrilintide
CAS: 1415456-99-3
Molecular Mass: 4409.01 g/mol
Molecular Formula: C194H312N54O59S2
PubChem ID: 171397054
Cagrilintide (also known as 0833) is a synthetic, long-acting acylated peptide analogue of human amylin, consisting of 37 amino acids with targeted sequence modifications and N-terminal lipidation via a γ-glutamyl-linked eicosanedioic acid (C20 diacid) fatty chain for enhanced stability and pharmacokinetic properties. Its primary sequence incorporates substitutions such as Asn14Glu and Val17Arg for improved solubility and helix stabilization via salt bridge formation, multiple proline insertions (e.g., at positions 25, 28, 29) to reduce β-sheet propensity and amyloid fibril formation, and a C-terminal proline amidation; it features a disulfide bridge between Cys³ and Cys⁸.
The full abbreviated sequence is: {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH₂ (Disulfide bridge: Cys³–Cys⁸).
Chemically, it has the molecular formula C₁₉₄H₃₁₂N₅₄O₅₉S₂ and a molar mass of approximately 4409.01 g/mol (CAS 1415456-99-3).
All items available on this website are intended exclusively for research and development purposes, including laboratory and analytical applications, and are not meant for human or animal consumption in any form. The products are not designed to diagnose, treat, cure, or prevent any medical conditions, and their associated claims have not been reviewed or approved by the U.S. Food and Drug Administration. Purus Peptides operates solely as a supplier of research chemicals and is neither a compounding pharmacy nor an outsourcing facility as defined by sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
Most products are sold in powder (lyophilized) form and require reconstitution with a suitable dilutant for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.